Sotera Health Company (SHC) Bundle
A Brief History of Sotera Health Company (SHC)
Company Overview
Sotera Health Company (SHC) trades on NASDAQ under the ticker symbol SHC. Headquartered in Cleveland, Ohio, the company provides mission-critical sterilization and testing services.
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Annual Revenue | $1.23 billion |
| Net Income | $145.6 million |
| Stock Price (as of January 2024) | $19.37 |
| Market Capitalization | $2.1 billion |
Business Segments
- Sterigenics (Sterilization Services)
- Nelson Labs (Testing Services)
- Synergy Health (Specialized Sterilization)
Key Operational Statistics
| Operational Metric | 2023 Value |
|---|---|
| Total Employees | 4,200 |
| Global Sterilization Facilities | 67 |
| Testing Laboratories | 29 |
Global Presence
Sotera Health operates in 13 countries across North America, Europe, and Asia-Pacific regions.
A Who Owns Sotera Health Company (SHC)
Major Shareholders
As of 2024, Sotera Health Company's ownership structure includes the following key shareholders:
| Shareholder | Percentage Ownership | Type of Ownership |
|---|---|---|
| Warburg Pincus LLC | 26.7% | Private Equity Firm |
| Bain Capital | 24.5% | Private Equity Firm |
| CCMP Capital | 21.3% | Private Equity Firm |
| Public Shareholders | 27.5% | Public Float |
Institutional Shareholders
- The Vanguard Group: 5.2% ownership
- BlackRock Inc.: 4.7% ownership
- State Street Corporation: 3.9% ownership
- Fidelity Management & Research: 3.5% ownership
Company Leadership
Key Executives with Ownership Stakes:
| Executive | Position | Ownership Percentage |
|---|---|---|
| Michael B. Petras Jr. | President and CEO | 0.8% |
| John M. Kreger | CFO | 0.5% |
Stock Information
Ticker Symbol: SHC
NYSE Listed: October 2020
Current Market Capitalization: $4.2 billion
Sotera Health Company (SHC) Mission Statement
Company Overview
Sotera Health Company (SHC) is a global provider of mission-critical sterilization and lab services. Headquartered in Mayfield Heights, Ohio, the company operates with a market capitalization of $4.23 billion as of January 2024.
Mission Statement Components
| Revenue (2023) | $1.27 billion |
| Global Facilities | 67 locations |
| Countries of Operation | 17 countries |
Core Business Segments
- Sterilization Services
- Lab Services
- Gamma Technologies
Key Performance Metrics
| Net Income (2023) | $193.4 million |
| Gross Margin | 46.3% |
| Operating Cash Flow | $362.5 million |
Strategic Focus Areas
Primary Mission Objectives:
- Ensuring medical device sterilization
- Providing contamination control solutions
- Supporting pharmaceutical and medical research
Operational Reach
| Total Employees | 2,800+ |
| Annual Sterilization Volume | Over 2.5 billion medical devices |
| Laboratory Testing Capacity | 500,000+ tests annually |
How Sotera Health Company (SHC) Works
Company Overview
Sotera Health Company (SHC) is a global commercial sterilization and medical device and technology company. Headquartered in Mayfield Heights, Ohio, the company trades on NASDAQ under the ticker symbol SHC.
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Annual Revenue | $1.28 billion |
| Net Income | $204.3 million |
| Gross Margin | 47.6% |
Business Segments
- Sterigenics (Sterilization Services)
- Nelson Labs (Laboratory Services)
- Nordion (Medical Isotope Technologies)
Service Offerings
Sterilization Services include contract sterilization for medical devices using various technologies:
- Gamma radiation sterilization
- Electron beam sterilization
- Ethylene oxide (EtO) sterilization
Global Presence
| Region | Number of Facilities |
|---|---|
| North America | 24 facilities |
| Europe | 12 facilities |
| Asia Pacific | 8 facilities |
Market Position
As of 2024, Sotera Health serves over 5,600 customers across more than 50 countries, with approximately 2,800 employees.
Key Client Industries
- Medical Device Manufacturers
- Pharmaceutical Companies
- Biotechnology Firms
- Healthcare Supply Chains
How Sotera Health Company (SHC) Makes Money
Revenue Streams
Sotera Health Company generates revenue through three primary business segments:
- Sterilization Services
- Gamma Sterilization Services
- Contract Laboratory Services
| Business Segment | 2022 Revenue | Percentage of Total Revenue |
|---|---|---|
| Sterilization Services | $1,048.4 million | 45.2% |
| Gamma Sterilization Services | $598.4 million | 25.8% |
| Contract Laboratory Services | $670.3 million | 28.9% |
Financial Performance
For the fiscal year 2022, Sotera Health reported:
- Total Revenue: $2,317.1 million
- Net Income: $308.5 million
- Adjusted EBITDA: $822.4 million
Client Base
Sotera Health serves multiple industries, including:
- Medical Device Manufacturers
- Pharmaceutical Companies
- Biotechnology Firms
- Diagnostic Equipment Manufacturers
Global Operations
| Region | Number of Facilities | Percentage of Global Revenue |
|---|---|---|
| North America | 48 | 65.3% |
| Europe | 22 | 22.7% |
| Asia Pacific | 15 | 12% |
Pricing Strategy
Average pricing per sterilization service:
- Medical Device Sterilization: $0.12 - $0.25 per cubic foot
- Gamma Sterilization: $0.18 - $0.35 per cubic foot
Sotera Health Company (SHC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.